Business · 04/02/2013

FDA Extends Comment Period for Draft Guidance on Clinical Trial Enrichment Strategies

The US Food and Drug Administration (FDA) is extending the comment period for its draft guidance on enrichment strategies for clinical trials to support the approval of human drugs and biological products, originally set to close on February 15, 2013, to allow more time for public input.